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Photo-activated localization microscopy (PALM) has revolutionized the field of fluorescence
microscopy by breaking the diffraction limit in spatial resolution. In this study, “acoustic wave sparsely
activated localization microscopy (AWSALM),” an acoustic counterpart of PALM, is developed to
super-resolve structures which cannot be resolved by conventional B-mode imaging. AWSALM uti-
lizes acoustic waves to sparsely and stochastically activate decafluorobutane nanodroplets by acoustic
vaporization and to simultaneously deactivate the existing vaporized nanodroplets via acoustic destruc-
tion. In this method, activation, imaging, and deactivation are all performed using acoustic waves.
Experimental results show that sub-wavelength micro-structures not resolvable by standard B-mode
ultrasound images can be separated by AWSALM. This technique is flow independent and does not
require a low concentration of contrast agents, as is required by current ultrasound super resolution tech-
niques. Acoustic activation and deactivation can be controlled by adjusting the acoustic pressure, which
remains well within the FDA approved safety range. In conclusion, this study shows the promise of a
flow and contrast agent concentration independent super-resolution ultrasound technique which has
potential to be faster and go beyond vascular imaging. VC 2018 Author(s). All article content, except
where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://
creativecommons.org/licenses/by/4.0/). https://doi.org/10.1063/1.5029874
Optical super-resolution imaging, using photo-activated
localization microscopy (PALM)1 and stochastic reconstruction
microscopy (STORM),2,3 is capable of resolving intracellular
organelles and the plasma membrane at spatial resolutions at
and below a few 10s of nanometers. The basic principle of
PALM is that a first light pulse will activate a subset of fluores-
cent proteins in the molecule sample. These fluorescent proteins
are then excited and imaged until bleached. A second light
pulse is then used to activate a new subset of fluorescent pro-
teins. Each spatially isolated fluorescent region in an image is
localized as a localization event. All localization events from
all images are then assembled into a super-resolution image.
The PALM and STORM techniques have revolutionized fluo-
rescence imaging by breaking the diffraction limit in spatial res-
olution. However, a key disadvantage of such optical
techniques is that biological tissue scatters light significantly
which limits their penetration depth in biological tissue and
makes in vivo imaging difficult. In-vivo microstructural changes
can be an important indicator for the detection and diagnosis of
certain diseases, such as ischemia, peripheral arterial disease,4
coronary heart disease,5 and tumor angiogenesis.6
Ultrasound is much less scattered by biological tissue than
optical radiation and is able to image in vivo structures in depth.
Gas-filled microbubble contrast agents are used in clinical ultra-
sound (US) imaging to improve blood flow signals and have a
diameter ranging between 1 and 10lm.7 These microbubble
contrast agents can resonate within the diagnostic ultrasound
imaging frequency range from 1 to 15MHz and generate stron-
ger acoustic signals than tissue, thus improving the contrast in
vascular imaging.8 However, the associated axial resolution
limit and its compromise with penetration depth pose chal-
lenges in imaging the microstructures such as microstructure
in vivo. Inspired by optical super-resolution methods, a low
concentration of flowing microbubbles was used to perform
ultrasound super-resolution imaging to visualize microvascula-
ture beyond the diffraction limit. Two-dimensional acoustic
super-resolution imaging has shown promise in both in vitro9
and in vivo10,11 studies using clinical ultrasound systems and
microbubble contrast agents. Three-dimensional acoustic
super-resolution imaging has been achieved using different
approaches in both in vitro12–14 and in vivo15 studies.
Since microbubbles are in an “activated” state (i.e., visi-
ble under ultrasound) at the point of injection current, super-
resolution imaging techniques using microbubbles rely on
low bubble concentration and sufficient flow. Such restric-
tions, together with the large size of microbubbles, mean that
only vascular flow can be imaged, and for small vessels with
slow flow, a longer acquisition time is required for the bub-
bles to replenish.
Nanodroplet contrast agents have been investigated as a
research alternative to microbubble contrast agents.16–19
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Nanodroplets are typically in the form of droplets of sub-
micron size and have been found to last longer during in-vivo
circulation compared to microbubbles.17 The sub-micron
size of nanodroplets potentially allows extravasation into
cancerous tissue due to its leaky vasculature and enhanced
permeability and retention effect.20 This could be beneficial
to cancer extravasation imaging. Moreover, the nanodroplets
can be selectively activated, both spatially and temporally, to
provide an ultrasound contrast signal.
High-boiling-point nanodroplets for super-resolution
photoacoustic imaging21 have been demonstrated recently.
This technique does not depend on flow, but photoacoustic
activation via a laser was required, which restricts its pene-
tration depth to regions that can be illuminated optically.
Compared to high-boiling-point nanodroplets, low-boiling-
point nanodroplets have a much lower activation threshold
and can be activated by diagnostic ultrasound pulses at
depth.22
In this study, we show that a high concentration of low-
boiling-point nanodroplets can be sparsely and stochastically
activated and then deactivated at will through controlling the
ultrasound amplitude applied which remains well within
clinical safety limits and thus demonstrate the acoustic coun-
terpart of PALM at depth.
Nanodroplet preparation was adapted from previously
described methods.23,24 Briefly, a lipid colloid was generated
by dissolving a 9:1 molar ratio of 1,2-dipalmitoyl-sn-glycero-
3-phosphocholine (DPPC) and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[amino(polyethylene glycol)–2000]
(DSPE-PEG-2000) into a solution of phosphate-buffered
saline (PBS), propylene glycol, and glycerol (16:3:1, v: v) to
achieve a total lipid concentration of 1mg/ml. All the lipids
described above were purchased from Avanti Polar Lipids,
Inc., USA. A volume of 1ml of lipid solution was added to a
2ml glass vial. The headspace of the vial was filled with
decafluorobutane gas (Fluoromed, USA) via an inlet needle
along with a vent needle. Mechanical agitation was applied
using a bubble shaker (Vialmix, USA) to produce the stable
and microscale bubbles composed of a gaseous decafluorobu-
tane core encapsulated by a lipid shell.
In order to condense microbubbles into nanodroplets,
the headspace of the vial was pressurized according to the
previously described methods. The vial of microbubbles was
immersed in an ice-salt bath (5 C to 10 C) followed by
pressurization with ambient air into the vial septum while
the vial contents remained in the ice-salt bath.
A NanoSight NS300 (Malvern Instruments Ltd., UK) was
used to measure the size and concentration of nanodroplet sol-
utions via nanoparticle tracking analysis (NTA), with the
nanoparticle size measurement range from 10 to 1000 nm.
According to the measurement, the mean diameter was
118.76 6.7 nm and the mean concentration was (3.516 0.26)
 1010 droplets/ml.
A crossed-tube phantom was fixed and immersed in a
water tank where the walls were covered with acoustic
absorbers. The crossed-tube phantom was made of two
200–lm-cellulose tubes (HemophanVR , Membrana) separated
by 30. The tube is a thin-walled cellulose capillary tube of
an internal diameter of 2006 15 lm, a wall thickness of
86 1lm in the dry state, and a length change under wet
conditions of 6 1% (specifications provided by the manufac-
turer). An L11–4v transducer equipped with ultrasound
research platform (Verasonics Vantage 128, Kirkland, USA)
was held 15mm above the center of the crossed-tubes. The
water temperature was maintained at 37 C. A diluted PCCA
solution (1.75 108 PCCAs/ml) was prepared in a beaker
at 37 C. A magnetic stirrer was put into the beaker for
mixing.
The ultrasound imaging system was characterized by
measuring the diffraction limited resolution and localization
precision. A 50 lm diameter tube was fixed horizontally in a
water tank to imitate a point scatterer as described in the pre-
vious literature.10 This was performed at depths of between
1 and 2 cm from the transducer face to test the changes in
point spread function (PSF) over the imaging depth. The res-
olution of the ultrasound imaging system was measured as
the mean value of full-width-half-maximum (FWHM) over
100 frames in the lateral and axial directions. The localiza-
tion precision was measured to be the standard deviation of
the measured center of mass over 100 frames. Figures
1(a)–1(c) show a representative image of tube cross-section
at a depth of 2 cm. The axial and lateral resolution was mea-
sured as a FWHM of 560 lm and 640 lm, respectively.
A customized continuous “Activation-Imaging” sequence
was developed and implemented on the ultrasound research
platform with an L11–4 linear array probe. The parameters of
the ultrasound pulses used are summarized in Table I. A
sequence of 128 2-cycle, 8MHz focused pulses were transmit-
ted at a mechanical index of 1.30 in order to sparsely activate
the nanodroplet population. One- cycle, 4MHz plane-wave
pulses were then used to acquire images of the vaporized
nanodroplets at a mechanical index of 0.25.
As illustrated in Figs. 1(d)–1(g), thirty (30) post-
activation images were acquired at a frame rate of 100
frames per second after each activation pulse sequence. Each
activation pulse sequence consists of 128 focused activation
pulses and it took 1.247ms to scan the focus across the field
of view at a depth of 15mm. The data acquisition period was
30 s. The received radiofrequency (RF) signals were recon-
structed using a delay-and-sum (DAS) beamformer previ-
ously demonstrated in Ref. 25. Singular value decomposition
(SVD) processing was used in order to obtain the activated
nanodroplet signals without the background signal.26
After SVD processing, the ultrasound image frames
were envelope detected. Super-localization was performed
on each ultrasound image after setting an image pixel value
threshold to reject the noise and detect potential vaporized
droplets. Each detected event in the image after thresholding
was compared to the point spread function of the system
according to their amplitude, area, and shape. Events that do
not fit a single point spread function are likely due to either
multiple detections or noise and were discarded after this
comparison. The location of single isolated vaporized drop-
lets was calculated by the “centroid” method.10 The centroid
of each localized vaporized droplet was computed by calcu-
lating the intensity weighted center of mass. The resulting
super-resolution map was created from all the localizations
detected over all the imaging frames.
The basic principle of acoustic wave sparsely activated
localization microscopy (AWSALM) is that the first
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activation pulse will sparsely activate a subgroup of nano-
droplets as the activation pulse pressure is selected to only
activate the largest most easily activated nanodroplets. These
activated nanodroplets will generate acoustic signals until
the next activation pulse.
From Fig. 2(a), it can be seen that, after activation, the
number of localization events of vaporized droplets
decreases over time. This is because a relatively high
mechanical index imaging pulse was used, and therefore, the
vaporized droplets were likely to undergo diffusion or coa-
lescence under such an imaging acoustic pressure.27 The
SVD processing acts to filter out the static signal and keep
the fluctuating signals. Thus, the movements of vaporized
droplets in different imaging frames provide more localiza-
tion events after each activation.
The second activation pulse will serve two purposes:
first to destroy the existing vaporized nanodroplets generated
from the previous activation pulse, and second, to activate a
new subgroup of nanodroplets. This continuous activation
and subsequent imaging can provide localizations of differ-
ent subgroups of vaporized nanodroplets. Figure 2(b) shows
representative frames of localizations of vaporized nano-
droplets after successive activations.
The sparse and apparently stochastic signals from acti-
vated nanodroplets, as shown in Fig. 2, may be due to a num-
ber of factors. A key factor is that the droplet population
consists of droplets with a statistical distribution of different
TABLE I. “Activation-Imaging” pulse sequence and the corresponding ultra-
sound parameters used in the experiments. Peak-negative-pressure (PNP) rep-
resents the spatial and temporal peak-negative-pressure. Mechanical index is
defined as the peak negative pressure of the acoustic wave (MPa) divided by










Activation Focus-pulse 8 2 3.68 1.30
Imaging Plane-wave 4 1 0.50 0.25
FIG. 2. (a) Representative image frames show the successive US image
frames of vaporized nanodroplet signals after one activation. (b)
Representative image frames show the first US image frame of vaporized
nanodroplet signals acquired after successive activations. Multimedia view:
https://doi.org/10.1063/1.5029874.1
FIG. 1. (a)–(c) Characterization of
ultrasound imaging system—
Verasonics 128 research platform
equipped with an L11-4v probe. (a) A
representative frame of 50-lm-diame-
ter tube cross section imaged at a dis-
tance of 2 cm. Measurements of the
full-width-half-maximum in the axial
(b) and lateral (c) directions, respec-
tively. (d) The illustration of custom-
ized “Activation-Imaging” ultrasound
pulse sequence used. (e)–(g) show
the normalized beam intensity profile
of three different activation focus-
pulses while scanning across the focal
region. The maximum acoustic pres-
sure is located at the pre-set focal
depth ¼ 15mm.
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size and shell properties. The size distribution of nanodrop-
lets can be seen from Fig. 3, and the nanodroplets are poly-
disperse with sizes ranging from about 50 to 300 nm. The
droplet size and shell properties are important factors deter-
mining the acoustic pressure threshold required for vaporiz-
ing the droplets. According to Ref. 28, it was found that the
activation threshold is inversely proportional to the size of a
nanodroplet, which means that at a relatively low acoustic
pressure, the relatively large droplets can be activated. The
optical demonstration of droplet activation with increasing
pressure has been shown previously.22 Therefore, only a
sparse subset of relatively large droplets randomly spatially
distributed in the tube phantom are sensitive to the low acti-
vation pressure used here (MI¼ 1.3), and the nanodroplets
were regarded to be sparsely activated by the first activation
pulse. The subsequent imaging pulses and next activation
pulse will cause a large percentage of activated nanodroplets
to be destroyed, including through shell rupture, diffusion,
and dissolution.24,29 The nanodroplets activated by the next
activation pulse may be affected by a range of factors. First,
they may be affected by any remaining nearby activated
nanodroplets generated by the previous activation.22 More
specifically, the wave emitted from a vaporised droplet (fol-
lowing insonation from the second activation pulse) could be
directional and have a random direction, and therefore, a
nanodroplet experiencing this wave in addition to the second
activation pulse is likely to be activated more easily.
Moreover, the non-linear distorted waves from nonlinear
propagation and from vaporised droplets may also have
superharmonics with wavelength close to the droplet size,
thus contributing to the initiation of droplet activation by the
next pulse.30 Second, they may be affected by any increase
in local temperature due to the activation and imaging
pulses, as nanodroplets have a lower activation pressure as
temperature increases.18 Furthermore, it may be possible for
the previous activation and imaging pulses to modify the
droplets, making them easier to vaporize subsequently.
Further research is required to determine which of these
effects dominates and if other mechanisms are involved.
Nevertheless, Fig. 2(b) demonstrates that new droplets are
activated after each new activation pulse.
Figures 4(a)–4(c) show the localization of vaporized
droplets at different activation pressure levels from MI ¼ 1.3
to 1.9. As the activation pressure level increases, there are
more vaporized droplets. However, many of these vaporized
droplets are not spatially isolated which introduces localiza-
tion errors. As can be seen from Fig. 4(d), the number of
total localization events increases from MI ¼ 1.1 until 1.4
where a plateau is reached. Although more nanodroplets are
activated as the mechanical index of activation pulse
increases, these vaporized nanodroplets may not be spatially
isolated and therefore may not contribute to detected locali-
zation events that are useful for super-resolution imaging. As
part of the post-processing, an algorithm was used to reject
non-isolated bubble signals. It can be seen in Fig. 4(d) that
the number of localization events after rejection increases
until it plateaued at MI ¼ 1.3, suggesting that this activation
level may be optimal in providing spatially isolated signals
for localization processing. The in vivo assessment of poten-
tial bio-effects from the low-boiling-point perfluorocarbon
droplet activation has already been carried out by
Nyankima.31 It found that the decafluorobutane droplet acti-
vation at this moderate pressure level (MI¼ 0.81–1.35) will
not induce any short-term or long-term bio-effects in the
rodent kidney.
Figure 5 shows the evaluation results on the non-flow
cross-tube phantom. In Fig. 5, two regions of interest (ROIs)
were selected to measure the FWHM of the image of the
tube. The left ROI is perpendicular to the tube and 15 tilted
to the vertical plane. Each ROI has a width of 0.5mm.
Figure 5(d) shows that the FWHM value is 210 lm for the
super-resolution image whereas it is 560 lm for the B-mode
image. For the right-hand ROI, the B-mode image cannot
distinguish the structure of two tubes but the FWHM mea-
surement in super-resolution image shows that two tubes are
210 lm apart as shown in Fig. 5(e).
In summary, this study is the demonstration of
AWSALM, a super-resolution ultrasound imaging technique
using acoustic activation and deactivation of nanodroplets at
an acoustic pressure within the FDA-approved safety range.
The much smaller size of the nanodroplets compared to
microbubble contrast agents means that the technique can
potentially super-resolve structures beyond the reach of the
current microbubble based ultrasound super-resolution
approaches. In addition, simultaneous sparse activation and
deactivation of nanodroplets can potentially reduce the
FIG. 3. The concentration and size distribution measurement of nanodroplet
solution measured using a NanoSight NS300. The black line and shaded
error bar represent the mean and standard deviation of concentration at each
diameter, respectively.
FIG. 4. Representative images show the visualization of localization of
vaporized nanodroplets under mechanical indices of (a) 1.3, (b) 1.6, and (c)
1.9. (d) The number of all localization events and the localization events
after rejection as the mechanical index of activation pulse increases.
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acquisition time of super-resolution imaging compared to the
time taken for conventional microbubble contrast agents to
flow across the volume imaged. AWSALM is flow and con-
centration independent and has the potential to super-resolve
micro-structures beyond the vasculature and also to reduce
the imaging acquisition time compared to super-resolution
imaging of conventional microbubble contrast agents flow-
ing through microvasculature.
This research was partially funded by the UK EPSRC
under Grant Nos. EP/N015487/1, EP/N014855/1, and EP/
M011933/1, and the CRUK Multidisciplinary Project Award
(No. C53470/A22353).
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